Exelixis
EXEL
#1754
Rank
ยฃ8.51 B
Marketcap
ยฃ31.63
Share price
-4.94%
Change (1 day)
14.65%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company